Bystander viral-specific CD8 T cells in tumors can also express these Trm markers (39), therefore CD39, a marker of chronic T cell activation is useful in distinguishing between the bystander and tumor-reactive T cell populations (38, 39). Here, ENTPD1 is linked to neoplasm.